InSilico Medicine Cayman (HKG: 03696)

Biotech · Hong Kong, MA · Founded 2014 · Publicly Held

InSilico Medicine Cayman TopCo is engaged in applying artificial intelligence (AI) solutions to drug discovery and development by leveraging its proprietary platforms. InSilico Medicine Cayman (HKG: 03696) is based in Hong Kong, MA and was founded in 2014. It is now publicly traded; this page covers its private-market history, where its last recorded valuation was $1.7 billion (Dec 2025). It has raised $842 million across 6 recorded rounds; the latest was a $13 million Series E extension (final close) in Jun 2025.

Last price · $/share
—
Implied valuation
$1.7B
Total raised
$841.9M
Last round
Series E extension (final close)
Jun 2025
How much has InSilico Medicine Cayman (HKG: 03696) raised?
$841.9Macross 6 recorded rounds · Sep 2019 – Jun 2025

Most recently, InSilico Medicine Cayman (HKG: 03696) raised $13.0M in its Series E extension (final close) (Jun 2025).

Free account
More of InSilico Medicine Cayman (HKG: 03696) with a free account
  • ·The complete investor list: 50 names
  • ·Watch InSilico Medicine Cayman (HKG: 03696): the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

InSilico Medicine Cayman (HKG: 03696) round by round

6 rounds
Jun 2025Series E extension (final close)$13.0M▮
Mar 2025Series E$110.0M▮
Aug 2022Series D2$35.0M▮
Jun 2022Series D$60.0M▮
Jun 2021Series C$255.0M▮
Sep 2019Series B$37.0M▮

How much has InSilico Medicine Cayman (HKG: 03696) raised?

InSilico Medicine Cayman (HKG: 03696) has raised $842 million across 6 recorded rounds since 2019. The largest was a $60 million Series D in Jun 2022; the most recent was a $13 million Series E extension (final close) in Jun 2025.

InSilico Medicine Cayman (HKG: 03696) investors

50 investors are on record for InSilico Medicine Cayman (HKG: 03696), including Hongshan Capital Group, F-Prime Capital, Qiming Venture Partners and Eight Roads. By type, the record holds 9 venture capital firms and 3 asset managers.

For fundraisers
Raising for a company like InSilico Medicine Cayman (HKG: 03696)?

50 investors have backed InSilico Medicine Cayman (HKG: 03696) — start your target list with the firms already writing checks in biotech.

See all 50 investors →

Frequently asked about InSilico Medicine Cayman (HKG: 03696)

How much has InSilico Medicine Cayman (HKG: 03696) raised?
InSilico Medicine Cayman (HKG: 03696) has raised $841.9M in total across 6 recorded funding rounds.
When was InSilico Medicine Cayman (HKG: 03696)'s last funding round?
InSilico Medicine Cayman (HKG: 03696)'s most recent recorded round was Series E extension (final close) in Jun 2025, raising $13.0M.